Nanox Imaging is trading at $0.32, up 5.89%, with the reason for the November 3 pre-market gain unclear.
- On November 2 at the TCT conference, Nanox Imaging announced updated clinical data for its investigational AVC software.
- The software remains under development and is not cleared for clinical use.
- A recent after-hours report also described the move as having no clear catalyst; it did not identify the data announcement as the cause of the pre-market rise.